Name: Bicara Therapeutics Inc. (BCAX) Balance Sheet
Creator: FinSpry

Bicara Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Bicara Therapeutics Inc. (BCAX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	489.71	230.44	4.16
Cash & Short-Term Investments	489.71	230.44	4.16
Accounts Receivable	0.00	0.10	0.07
Inventory	0.00	0.00	0.00
Other Current Assets	12.82	0.53	0.76
Total Current Assets	502.53	231.07	4.98
Non-Current Assets
Property, Plant & Equipment (Net)	0.85	0.82	0.64
Other Non-Current Assets	6.62	1.99	0.94
Total Non-Current Assets	7.46	2.91	1.72
Total Assets	510.00	233.98	6.70
Current Liabilities
Accounts Payable	4.51	3.19	5.14
Short-Term Debt	0.61	0.00	0.00
Accrued Liabilities	9.79	11.61	18.76
Other Current Liabilities	12.88	0.00	0.00
Total Current Liabilities	17.99	15.09	23.90
Non-Current Liabilities
Long-Term Debt	0.13	0.37	0.00
Deferred Tax Liabilities	59.20	0.00	0.00
Other Non-Current Liabilities	0.00	0.02	0.09
Total Non-Current Liabilities	0.13	367.67	81.61
Total Liabilities	18.12	15.47	23.98
Stockholders' Equity
Common Stock	0.01	0.00	0.00
Retained Earnings	-221.02	-153.02	-101.04
Additional Paid-in Capital	712.88	4.25	2.23
Shares Outstanding	54.44	51.76	51.76
Total Stockholders' Equity	491.88	218.51	-17.28
Total Liabilities & Equity	510.00	233.98	6.70